1. Home
  2. EVAX vs JNVR Comparison

EVAX vs JNVR Comparison

Compare EVAX & JNVR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVAX
  • JNVR
  • Stock Information
  • Founded
  • EVAX 2008
  • JNVR 2018
  • Country
  • EVAX Denmark
  • JNVR United States
  • Employees
  • EVAX N/A
  • JNVR N/A
  • Industry
  • EVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • JNVR Finance: Consumer Services
  • Sector
  • EVAX Health Care
  • JNVR Finance
  • Exchange
  • EVAX Nasdaq
  • JNVR Nasdaq
  • Market Cap
  • EVAX 8.7M
  • JNVR 7.3M
  • IPO Year
  • EVAX 2021
  • JNVR 2023
  • Fundamental
  • Price
  • EVAX $2.78
  • JNVR $5.05
  • Analyst Decision
  • EVAX Strong Buy
  • JNVR
  • Analyst Count
  • EVAX 3
  • JNVR 0
  • Target Price
  • EVAX $33.33
  • JNVR N/A
  • AVG Volume (30 Days)
  • EVAX 6.9M
  • JNVR 17.5K
  • Earning Date
  • EVAX 03-26-2025
  • JNVR 03-27-2025
  • Dividend Yield
  • EVAX N/A
  • JNVR N/A
  • EPS Growth
  • EVAX N/A
  • JNVR N/A
  • EPS
  • EVAX N/A
  • JNVR N/A
  • Revenue
  • EVAX $3,295,000.00
  • JNVR $1,820,969.00
  • Revenue This Year
  • EVAX $9,039.73
  • JNVR N/A
  • Revenue Next Year
  • EVAX $1.47
  • JNVR N/A
  • P/E Ratio
  • EVAX N/A
  • JNVR N/A
  • Revenue Growth
  • EVAX N/A
  • JNVR N/A
  • 52 Week Low
  • EVAX $2.22
  • JNVR $3.37
  • 52 Week High
  • EVAX $22.50
  • JNVR $11.84
  • Technical
  • Relative Strength Index (RSI)
  • EVAX 41.99
  • JNVR 49.94
  • Support Level
  • EVAX $2.30
  • JNVR $5.07
  • Resistance Level
  • EVAX $4.05
  • JNVR $5.61
  • Average True Range (ATR)
  • EVAX 1.10
  • JNVR 0.47
  • MACD
  • EVAX 0.02
  • JNVR -0.02
  • Stochastic Oscillator
  • EVAX 7.39
  • JNVR 27.01

About EVAX Evaxion Biotech

Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.

About JNVR Janover Inc.

Janover Inc is a B2B fintech marketplace providing a platform for commercial property borrowers and lenders. It provides a technology platform that connects commercial mortgage borrowers looking for debt to refinance, build, or buy commercial property including apartment buildings to commercial property lenders including banks, credit unions, REITs, debt funds, and more looking to deploy capital into commercial mortgages. The firm caters to two consumer segments: lenders and borrowers. It derives the majority of its revenue from transaction fees.

Share on Social Networks: